ICICI Bank's stock rallies toward a record as decline in net interest margin is seen 'nearing its end'
By Tomi Kilgore
India-based bank's stock wipes away the weakness seen after disappointing NIM results from rival HDFC Bank last week
Shares of ICICI Bank Ltd. rallied into record territory Monday as investors cheered the India-based bank's fiscal third-quarter results, which showed that the compression in net interest margin was nearing its end.
The results were a relief, because disappointing NIM results from rival HDFC Bank Ltd. (HDB) (IN:500180) weighed on ICICI's stock (IBN) (IN:532174) last week.
ICICI's U.S.-listed stock surged 4% in morning trading to trade above the current record closing price of $24.69, reached on Dec. 13.
ICICI reported over the weekend that NIM for the quarter to Dec. 31 was 4.43%, down from 4.53% in the previous quarter and below the 4.65% reported in the same period a year ago.
J.P. Morgan analyst Saurabh Kumar was encouraged by the results, saying that the NIM decline was "along expected lines." He reiterated the stock's overweight rating and lifted his stock-price target to INR1,180 (equivalent to $14.20) from INR1,150 ($13.84), with the new target implying 17% upside from the latest prices.
The bank also reported third-quarter profit, total revenue and net interest income that rose above expectations, according to FactSet.
And deposits as of Dec. 31 were up 2.9% from the end of the sequential second quarter and up 18.7% from a year ago, while the overall loan portfolio increased 3.9% sequentially and jumped 18.5% on the year.
Bernstein's Pranav Gundlapalle said the results were "steady and healthy" and reflected continued strength in loan growth and return on assets, and only "slight" margin compression.
He said the results indicate that NIM compression is "nearing its end," with fiscal 2024 NIM now expected to be at a similar level to that of fiscal 2023.
"Overall, a healthy set of numbers with the key positive being a still healthy NIM (despite the sequential compression) and the continued high [return on assets]," Gundlapalle wrote in a note to clients.
He reiterated his market-perform rating and INR1,150 stock-price target.
ICICI's stock has climbed 11.6% over the past three months, while the iShares MSCI India exchange-traded fund INDA has hiked up 13.5% and the S&P 500 index SPX has run up 15.2%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
01-22-24 1020ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Amazon Earnings: AWS Growth Accelerates and Profit Margins Improve
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?